3,6-dimethylisoxazolo[5,4-b]pyridine-4-carboxylic acid | 900136-98-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异恶唑并吡啶类
• 英文名称: 3,6-dimethylisoxazolo[5,4-b]pyridine-4-carboxylic acid
• 英文别名: 3,6-dimethyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylic acid
• CAS: 900136-98-3
• 化学式: C₉H₈N₂O₃
• mdl: MFCD08166692
• 分子量: 192.174
• InChiKey: FSGQUBXBQDIYBH-UHFFFAOYSA-N

物化性质

• 熔点：
  234 °C
• 沸点：
  360.1±37.0 °C(Predicted)
• 密度：
  1.393±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  76.2
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3,6-dimethylisoxazolo[5,4-b]pyridine-4-carboxylic acid 、 methyl 5-[(3-phenylpropyl)amino]pentanoate hydrochloride 在 三乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 水 、 lithium hydroxide 作用下， 以 N,N-二甲基乙酰胺 、 1,4-二氧六环 、 甲醇 为溶剂， 反应 1.25h， 以20.2%的产率得到5-[(3,6-dimethyl[1,2]oxazolo[5,4-b]pyridine-4-carbonyl)(3-phenylpropyl)amino]pentanoic acid
  参考文献：
  名称：

  [EN] TERTIARY AMIDES AND METHOD OF USE
  [FR] AMIDES TERTIAIRES ET PROCÉDÉ D'UTILISATION

  摘要：

  公开号：

  WO2017177004A8

文献信息

• [EN] ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS<br/>[FR] COMPOSÉS URÉE HÉTÉROCYCLIQUES SUBSTITUÉS PAR AMIDE ET SULFONAMIDE ANTIBACTÉRIENS
  申请人：REPLIDYNE INC

  公开号：WO2009015208A1

  公开（公告）日：2009-01-29

  The present invention provides novel amide and sulfonamide substituted heterocyclic urea compounds having useful antibacterial activity. Use of these compounds as pharmaceutical compositions and method of their production are also provided.

  本发明提供了具有有用抗菌活性的新型酰胺和磺胺基取代的杂环脲化合物。同时还提供了将这些化合物用作药物组合物以及它们的生产方法。
• ARYL CARBOXAMIDE DERIVATIVES AS TTX-S BLOCKERS
  申请人：Yamagishi Tatsuya

  公开号：US20120232052A1

  公开（公告）日：2012-09-13

  The present invention relates to aryl carboxamide derivatives of formula (I), wherein Ar 1 is phenyl; Ar 2 is aryl; n is 1-4; X is —O—, —S—, —SO— or —SO 2 —, a prodrug thereof or a pharmaceutically acceptable salt thereof, which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of such disorders and diseases as pain in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases as pain in which voltage gated sodium channels are involved.

  本发明涉及公式（I）的芳基羧酰胺衍生物，其中Ar1是苯基；Ar2是芳基；n为1-4；X为—O—、—S—、—SO—或—SO2—，其前体药物或其药学上可接受的盐，具有阻断电压门控钠通道如TTX-S通道的活性，并在治疗或预防涉及电压门控钠通道的疾病和疾病，如疼痛方面中有用。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病和疾病，如疼痛方面的使用。
• ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS
  申请人：Crestone, Inc.

  公开号：EP2200440A1

  公开（公告）日：2010-06-30
• HERBICIDAL ISOXAZOLO[5,4-B]PYRIDINES
  申请人：BASF SE

  公开号：EP2595995B1

  公开（公告）日：2015-11-25
• TERTIARY AMIDES AND METHOD OF USE
  申请人：AbbVie Inc.

  公开号：US20190119200A1

  公开（公告）日：2019-04-25

  Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein G 1 , G 2 , G 3 , L 1 , L 2 , and L 3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by the modulation of lysophosphatidic acid receptor 1. Methods for making the compounds are described. Also described are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.